Improving safety, reducing costs and increasing efficacy in Phase I studies

Early drug development is continually faced with regulatory, operational and clinical dilemmas causing costly delays to the transition from preclinical to Phase I clinical studies. Join this essential forum to assess the significant advances in scientific and technological approaches for obtaining clinical data at earlier stages of drug development. 5 reasons not to miss Phase I Clinical Trials 2007! 1. An information packed two-day conference addressing key issues in Phase I and translational studies 2. Two practical one-day workshop sessions giving you a complete working overview of TQT studies and project management in Phase I 3. A one-day pre-conference symposium focusing on biomarkers and their vital role in early drug development 4. Case study sessions demonstrating the latest strategies to drive down costs and increase study effectiveness 5. A world-class speaker panel ready to share their experiences

Registration required:

Yes

Free:

No